Drugs / Prontosan
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT07391748 | Jan → Apr 2026 overdue | decubitus ulcer | FISABIO Foundation | Not yet recruiting | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT01939145 | Sep 2013 → Jul 2014 | skin infection | Georgetown University | Completed | No outcome recorded |
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT06297967 Comparator | Apr 2025 → Mar 2027 expected | chronic ulcer of skin | Consorci Sanitari de l'Alt Penedès i Garraf | Recruiting | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT06309368 Comparator | Mar 2024 → Dec 2028 expected | large intestine disorder | University of Nevada, Las Vegas | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Prontosan | “The intervention consists of the topical application of a gel containing polyhexanide and biguanide (Prontosan®), either alone or in combination with a silver-containing...” NCT07391748 ↗3“Prontosan (B Braun, Bethlehem, PA) is 0.1% polyhexanide, 0.1% betaine, sodium hydroxide, and purified water.” NCT01939145 ↗ “The incision will then be irrigated using direct stream into the wound with 350cc of Prontosan.” NCT06309368 ↗ |
| Modality | Other / unclassified | “0.1% betaine and 0.1 % polyhexamethylene biguanide antimicrobial solution” NCT06309368 ↗ |
| Route | Topical | “This solution is an FDA approved device indicated for topical irrigation.” NCT01939145 ↗ |